litlas
Log inCreate account

Michael J. Kelley

Active 1974–2025

77
Papers
20,409
Citations
50
h-index
71
i10-index

Citations

Citations per year for Michael J. Kelley1966: 1 citations1975: 1 citations1977: 3 citations1978: 3 citations1979: 4 citations1981: 6 citations1982: 2 citations1984: 4 citations1985: 3 citations1986: 7 citations1987: 2 citations1988: 8 citations1989: 14 citations1990: 17 citations1991: 12 citations1992: 15 citations1993: 12 citations1994: 13 citations1995: 37 citations1996: 29 citations1997: 40 citations1998: 98 citations1999: 148 citations2000: 230 citations2001: 249 citations2002: 276 citations2003: 272 citations2004: 228 citations2005: 233 citations2006: 249 citations2007: 219 citations2008: 257 citations2009: 217 citations2010: 228 citations2011: 199 citations2012: 174 citations2013: 160 citations2014: 127 citations2015: 120 citations2016: 152 citations2017: 128 citations2018: 111 citations2019: 371 citations2020: 407 citations2021: 335 citations2022: 257 citations2023: 186 citations2024: 296 citations2025: 103 citations2026: 4 citations1967–1974: no citations, so these years are not shown1976: no citations, so this year is not shown1980: no citations, so this year is not shown1983: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,725 citing papers, 34.4% of this breakdownChina: 514 citing papers, 6.5% of this breakdownUnited Kingdom: 485 citing papers, 6.1% of this breakdownJapan: 462 citing papers, 5.8% of this breakdownGermany: 386 citing papers, 4.9% of this breakdownFrance: 313 citing papers, 4% of this breakdownItaly: 308 citing papers, 3.9% of this breakdownAustralia: 287 citing papers, 3.6% of this breakdownCanada: 250 citing papers, 3.2% of this breakdownNetherlands: 193 citing papers, 2.4% of this breakdownSwitzerland: 169 citing papers, 2.1% of this breakdownSpain: 158 citing papers, 2% of this breakdown
0%34.4%Other 21.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology49.2%
  • Medicine31.5%
  • Immunology and Microbiology8.5%
  • Neuroscience2.7%
  • Psychology2.1%
  • Engineering1.2%
  • Other4.8%

Topics

  • Bone Metabolism and Diseases8.4%
  • Bone health and treatments5.8%
  • Cancer, Hypoxia, and Metabolism4.4%
  • Bone health and osteoporosis research2.5%
  • NF-κB Signaling Pathways2.4%
  • Immune Response and Inflammation2.3%
  • Other74.2%

Coauthors

All papers

Open in search
  1. Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

    Authors: Pierre Sonveaux, Frédérique Végran, Thies Schroeder, Melanie Wergin, Julien Verrax, Zahid N. Rabbani, Christophe J. De Saedeleer, Kelly M. Kennedy, Caroline Diepart, Bénédicte F. Jordan, Michael J. Kelley, Bernard Gallez, M Wahl, Olivier Féron, Mark W. Dewhirst - Journal of Clinical Investigation 2008 cited by 1,611

  2. Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density

    Authors: W. Scott Simonet, Dave Lacey, Colin R. Dunstan, Michael J. Kelley, Ming‐Shi Chang, Roland Lüthy, Hung Q. Nguyen, Scott K. Wooden, L Bennett, Thomas C. Boone, Grant Shimamoto, M DeRose, Robin Elliott, Anne Colombero, Hong‐Lin Tan, Geraldine Trail, John K. Sullivan, Elyse Davy, Nathan Bucay, Lisa Renshaw-Gegg, Tamar M. Hughes, David Hill, W Pattison, Pauline Campbell, Shane A. Sander, Gwyneth Van, J E Tarpley, Patricia L. Derby, R Lee, W.J Boyle - Cell 1997 cited by 5,141

  3. Implementation of Lung Cancer Screening in the Veterans Health Administration

    Authors: Linda Kinsinger, Charles Anderson, Jane Kim, Martha Larson, Stephanie H. Chan, Heather A. King, Kathryn Rice, Christopher G. Slatore, Nichole T. Tanner, Kathleen Pittman, Robert J. Monte, Rebecca B. McNeil, Janet M. Grubber, Michael J. Kelley, Dawn Provenzale, Santanu Datta, Nina S. Sperber, Lottie K. Barnes, David H. Abbott, Kellie J. Sims, Lawrence Whitley, R. Ryanne Wu, George L. Jackson - JAMA Internal Medicine 2017 cited by 372

  4. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

    Authors: Hailing Hsu, David L. Lacey, Colin R. Dunstan, Irina Solovyev, Anne Colombero, Emma Timms, Hong‐Lin Tan, Gary Elliott, Michael J. Kelley, Ildiko Sarosi, Ling Wang, Xing-Zhong Xia, Robin Elliott, Laura Chiu, Tabitha Black, Sheila Scully, Casey Capparelli, Sean Morony, Grant Shimamoto, Michael Bass, William J. Boyle - National Academy of Sciences, Proceedings of the National Academy of Sciences 1999 cited by 1,639

  5. Mouse models of MYH9-related disease: mutations in nonmuscle myosin II-A

    Authors: Yingfan Zhang, Mary Anne Conti, Daniela Malide, Fan Dong, Aibing Wang, Yelena A. Shmist, Chengyu Liu, Patricia M. Zerfas, Mathew P. Daniels, Chi‐Chao Chan, Elliott D. Kozin, Bechara Kachar, Michael J. Kelley, Jeffrey B. Kopp, Robert Adelstein - Blood 2011 cited by 185

  6. Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System: 2010 Update

    Authors: Leah L. Zullig, Kellie J. Sims, Rebecca B. McNeil, Christina D. Williams, George L. Jackson, Dawn Provenzale, Michael J. Kelley - Military Medicine 2017 cited by 137

  7. Lipopolysaccharide (LPS)-binding protein accelerates the binding of LPS to CD14.

    Authors: Eric Hailman, Henri S. Lichenstein, Mark M. Wurfel, David S. Miller, David A. Johnson, Michael J. Kelley, Leigh Busse, Mark M. Zukowski, Samuel D. Wright - The Journal of Experimental Medicine 1994 cited by 753

  8. Obesity and the Neurocognitive Basis of Food Reward and the Control of Intake

    Authors: Hisham Ziauddeen, Miguel Alonso‐Alonso, James O. Hill, Michael J. Kelley, Naiman A. Khan - Advances in Nutrition 2015 cited by 147

  9. Adoption of Extended-Interval Dosing of Single-Agent Pembrolizumab and Comparative Effectiveness vs Standard Dosing in Time-to-Treatment Discontinuation

    Authors: Garth W. Strohbehn, Robert G. Holleman, Jennifer Burns, Mandi L. Klamerus, Michael J. Kelley, Eve A. Kerr, Nithya Ramnath, Timothy P. Hofer - JAMA Oncology 2022 cited by 24

  10. APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity

    Authors: Gang Yu, T. Boone, John Delaney, Nessa Hawkins, Michael J. Kelley, M. Ramakrishnan, Susan McCabe, Wanrong Qiu, Masayo Kornuc, Xing-Zhong Xia, Jane Guo, Marina Stolina, William J. Boyle, Ildiko Sarosi, Hailing Hsu, Giorgio Senaldi, Lars E. Theill - Nature Immunology 2000 cited by 362

  11. Cancer Incidence Among Patients of the U.S. Veterans Affairs Health Care System

    Authors: Leah L. Zullig, George L. Jackson, Raye Anne Dorn, Dawn Provenzale, Rebecca B. McNeil, Catherine M. Thomas, Michael J. Kelley - Military Medicine 2012 cited by 184

  12. Adopting Weight-Based Dosing With Pharmacy-Level Stewardship Strategies Could Reduce Cancer Drug Spending By Millions

    Authors: Alex K. Bryant, Zoey Chopra, Donna M. Edwards, Adam S. Whalley, Brian Bazzell, Julie Moeller, Michael J. Kelley, A. Mark Fendrick, Eve A. Kerr, Nithya Ramnath, Michael D. Green, Timothy P. Hofer, Garth W. Strohbehn - Health Affairs 2023 cited by 15

  13. T (brachyury) gene duplication confers major susceptibility to familial chordoma

    Authors: Xiaohong R. Yang, David Ng, David A. Alcorta, Norbert J. Liebsch, Eamonn Sheridan, Sufeng Li, Alisa M. Goldstein, Dilys M. Parry, Michael J. Kelley - Nature Genetics 2009 cited by 304

  14. Human Nonsyndromic Hereditary Deafness DFNA17 Is Due to a Mutation in Nonmuscle Myosin MYH9

    Authors: Anil K. Lalwani, Jayne A. Goldstein, Michael J. Kelley, William M. Luxford, Caley M. Castelein, Anand N. Mhatre - The American Journal of Human Genetics 2000 cited by 235

  15. Immunization With Mutantp53- andK-ras–Derived Peptides in Cancer Patients: Immune Response and Clinical Outcome

    Authors: David P. Carbone, I. Frank Ciernik, Michael J. Kelley, Malcolm C. Smith, Sorena Nadaf, Denise Kavanaugh, V. Ellen Maher, Michael Stipanov, David Contois, Bruce E. Johnson, C D Pendleton, Burkhardt Seifert, Charley Carter, Elizabeth J. Read, Jay J. Greenblatt, Lois E. Top, Morris I. Kelsey, John D. Minna, Jay A. Berzofsky - Journal of Clinical Oncology 2005 cited by 169

  16. Valuing the Diversity of Research Methods to Advance Nutrition Science

    Authors: Richard D. Mattes, Sylvia Rowe, Sarah D. Ohlhorst, Andrew W. Brown, Daniël J. Hoffman, DeAnn Liska, Edith J. M. Feskens, Jaapna Dhillon, Katherine L. Tucker, Leonard H. Epstein, Lynnette M. Neufeld, Michael J. Kelley, Naomi K. Fukagawa, Roger A. Sunde, Steven H. Zeisel, Anthony J. Basile, Laura Borth, Emahlea Jackson - Advances in Nutrition 2022 cited by 39

  17. Veterans Health Administration National TeleOncology Service

    Authors: Leah L. Zullig, Whitney Raska, Gina McWhirter, Scott E. Sherman, Danil V. Makarov, Daniel Becker, Heather A. King, John Pura, Amy S. Jeffreys, Susanne Danus, Vida Almario Passero, Karen M. Goldstein, Michael J. Kelley - JCO Oncology Practice 2023 cited by 18

  18. Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B

    Authors: Everett E. Vokes, James E. Herndon, Michael J. Kelley, M. Giulia Cicchetti, Nithya Ramnath, H. Barry Neill, James N. Atkins, Dorothy Watson, Wallace Akerley, Mark R. Green - Journal of Clinical Oncology 2007 cited by 473

  19. Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2

    Authors: Jonathan D. Oliner, Hosung Min, Juan Leal, Dongyin Yu, Shashirekha Rao, Edward You, Tang Xiu, Hae Jin Kim, Susanne Meyer, Seog Joon Han, Nessa Hawkins, Robert Rosenfeld, Elyse Davy, Kevin C. Graham, Frederick W. Jacobsen, Shirley Stevenson, Joanne Ho, Qing Chen, Thomas Hartmann, Mark L. Michaels, Michael J. Kelley, Luke Li, Karen Sitney, Frank Martin, Ji-Rong Sun, Nancy R. Zhang, John Lu, Juan Estrada, Rakesh Kumar, Angela Coxon, Stephen A. Kaufman, James K. Pretorius, Sheila Scully, Russ Cattley, Marc Payton, Steve Coats, Linh T. Nguyen, Binodh DeSilva, Anthony Ndifor, Isaac J. Hayward, Robert Radinsky, T. Boone, Richard Kendall - Cancer Cell 2004 cited by 469

  20. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action

    Authors: Paul W. Finch, Xi He, Michael J. Kelley, Aykut Üren, R. Paul Schaudies, Nicholas C. Popescu, Stuart Rudikoff, Stuart A. Aaronson, Harold Varmus, Jeffrey S. Rubin - National Academy of Sciences, Proceedings of the National Academy of Sciences 1997 cited by 418

  21. A pathway-based classification of human breast cancer

    Authors: Michael L. Gatza, Joseph E. Lucas, William T. Barry, Jong Wook Kim, Quanli Wang, Matthew D. Crawford, Michael Datto, Michael J. Kelley, Bernard Mathey-Prévôt, Anil Potti, Joseph R. Nevins - National Academy of Sciences, Proceedings of the National Academy of Sciences 2010 cited by 340

  22. Transportation as a barrier to colorectal cancer care

    Authors: Shelley A. Jazowski, Isabelle P. Sico, Jennifer H. Lindquist, Valerie A. Smith, Hayden B. Bosworth, Susanne Danus, Dawn Provenzale, Michael J. Kelley, Leah L. Zullig - BMC Health Services Research 2021 cited by 26

  23. De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer

    Authors: Alex K. Bryant, K. Nathan Sankar, Lili Zhao, Garth W. Strohbehn, David J. Elliott, Drew Moghanaki, Michael J. Kelley, Nithya Ramnath, Michael D. Green - European Journal of Cancer 2022 cited by 24

  24. Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) Clinical Program at Initial Test Sites

    Authors: Olivia M Dong, Megan C. Roberts, R. Ryanne Wu, Corrine I. Voils, Nina Sperber, Kara L. Gavin, Jill Bates, Catherine Chanfreau‐Coffinier, Michael Naglich, Michael J. Kelley, Jason L. Vassy, Peruvemba Sriram, Craig Heise, Salvador Rivas, Maria Ângela Gonçalves de Oliveira Ribeiro, Jennifer Chapman, Deepak Voora - Pharmacogenomics 2021 cited by 18